ReviewThe Korean journal of helicobacter and upper gastrointestinal research2024
[Endoscopic Treatment and Prevention of Acute Variceal Hemorrhage].
Review in The Korean journal of helicobacter and upper gastrointestinal research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastroesophageal varices occur in more than half of patients with cirrhosis and the incidence increases as liver function worsens. Although the mortality rate for acute variceal bleeding has decreased with the development of variceal endoscopic hemostasis and administration of vasoactive drugs and prophylactic antibiotics, it still reaches 20%. Therefore, surveillance of variceal occurrence and the prevention of their bleeding is very important in patients with cirrhosis. In patients with liver cirrhosis accompanied by portal hypertension, esophagogastroduodenoscopy should be performed to diagnose varices and stratify their bleeding risk. The interval of endoscopic surveillance is adjusted according to variceal condition and cirrhosis severity. If varices are diagnosed, primary prophylaxis (e.g., non-selective beta-blockers or endoscopic prophylaxis) is required to prevent variceal bleeding. Appropriate treatment, including timely endoscopic hemostasis, should be performed in patients with acute variceal bleeding, and secondary prophylaxis is required to prevent rebleeding. Endoscopic variceal ligation is the recommended endoscopic treatment for acute esophageal variceal bleeding; endoscopic variceal obstruction is usually recommended in patients with gastric varices. To prevent bleeding, endoscopic surveillance should be performed at regular intervals until the varices have been eradicated, and endoscopic followup should be performed periodically even after their disappearance. In this review, we investigate the role of endoscopy in the treatment and management of gastroesophageal varices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.